Cancer

News

BMS shares fall on mixed cancer immunotherapy results

Bristol-Myers Squibb’s shares have fallen sharply in pre-opening trading after mixed results from its cancer immunotherapy Opdivo in lung cancer.

News

More woe for Roche as another Rituxan biosimilar approved in...

The FDA has approved a second biosimilar of Roche’s leukaemia drug Rituxan, along with yet another biosimilar of AbbVie’s inflammatory diseases blockbuster Humira.

Deep Dive

Did cancer clinical trials stay on track at ASCO 2019?

Chicago is recovering after 40,000 oncologists and cancer experts descended on the city for this year’s ASCO conference.

Views & Analysis

The promising future of RNA

RNA technology-based therapeutics are a new and novel way to treat diseases.

Views & Analysis

Can in vivo imaging deliver the full potential of immunother...

In the quest to control cancer we now face the challenge of translating our increasing insights into the cancer-immunity cycle into more effective immune therapies.

News

Natural killer cells are a type of lymphocytes which destroy cancer cells and other altered cells releasing cytotoxic granules.

Transgene begins trials of head and neck cancer vaccine

Virus-based immunotherapy biotech Transgene is to begin clinical trials of its head and neck cancer drug candidate TG4050 after gaining regulatory clearance from the UK regulator.<

BMS shares fall on mixed cancer immunotherapy results

More woe for Roche as another Rituxan biosimilar approved in...

Did cancer clinical trials stay on track at ASCO 2019?

The promising future of RNA

Can in vivo imaging deliver the full potential of immunother...

Transgene begins trials of head and neck cancer vaccine

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Cancer

Editor's Picks